Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46.4M
-
Number of holders
-
246
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
-494K
-
Total reported value, excl. options
-
$864M
-
Value change
-
-$24.4M
-
Put/Call ratio
-
1.32
-
Number of buys
-
94
-
Number of sells
-
-119
-
Price
-
$20.22
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q3 2023
290 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q3 2023.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 46.4M outstanding shares and own 92.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.13M shares), VANGUARD GROUP INC (5.47M shares), RGM Capital, LLC (2.95M shares), DIMENSIONAL FUND ADVISORS LP (2.91M shares), Paradice Investment Management LLC (2.27M shares), WESTWOOD HOLDINGS GROUP INC (2.11M shares), STATE STREET CORP (1.99M shares), T. Rowe Price Investment Management, Inc. (1.63M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.09M shares), and GEODE CAPITAL MANAGEMENT, LLC (948K shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.